Pediatric and Geriatric Pharmacology Practice Questions

Q: What agent is used for pupil dilatation in children?

Atropine. **Explanation:** In pediatric ophthalmology, the drug of choice for pupil dilatation and cycloplegic refraction is **Atropine**. **1. Why Atropine is Correct:** Children have very high accommodative power due to a strong ciliary muscle. To perform an accurate refraction (especially to detect latent hypermetropia or accommodative esotropia), complete paralysis of the ciliary muscle (**cycloplegia**) is required. Atropine is the most potent cycloplegic available. It is typically administered as a 1% ointment or drops for 3 days prior to the examination to ensure maximal effect. **2. Why the other options are incorrect:** * **Homatropine:** It is a semi-synthetic derivative of atropine but is significantly less potent. It is rarely used for refraction in children because it may result in incomplete cycloplegia. * **Tropicamide:** While it has the fastest onset and shortest duration (making it the drug of choice for adults), its cycloplegic action is too weak for the strong accommodative reflex of a child. * **Phenylephrine:** This is a sympathomimetic (alpha-1 agonist) that causes mydriasis (dilation) but **no cycloplegia**. It is often used as an adjunct but cannot be used alone for pediatric refraction. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Atropine is the DOC for children <7 years; Cyclopentolate is preferred for children 7–12 years; Tropicamide is preferred for adults. * **Systemic Toxicity:** In children, always apply pressure over the lacrimal sac (punctal occlusion) after instilling drops to prevent systemic absorption, which can cause "Atropine flushing," fever, and tachycardia. * **Contraindication:** Avoid atropine in children with Down Syndrome, as they may show an exaggerated pupillary response and heart rate.

Q: Which vitamin deficiency is most commonly seen in a pregnant mother receiving phenytoin therapy for epilepsy?

Folic acid. **Explanation:** **Phenytoin** is a widely used antiepileptic drug known for its specific metabolic side effects, particularly regarding folate metabolism. **Why Folic Acid is the Correct Answer:** Phenytoin causes folic acid deficiency through three primary mechanisms: 1. **Inhibition of Absorption:** It inhibits the enzyme intestinal conjugase, which is required to break down dietary polyglutamates into absorbable monoglutamates. 2. **Enzyme Induction:** As a potent inducer of hepatic CYP450 enzymes, phenytoin increases the demand for folate as a co-factor in drug metabolism. 3. **Antagonism:** It may interfere with the uptake of folate by cells. In pregnant women, this deficiency is critical as it significantly increases the risk of **Neural Tube Defects (NTDs)** and can lead to megaloblastic anemia. **Why Other Options are Incorrect:** * **Vitamin B6 (Pyridoxine):** Deficiency is classically associated with **Isoniazid (INH)** therapy, not phenytoin. * **Vitamin B12:** While B12 deficiency also causes megaloblastic anemia, phenytoin specifically targets folate pathways. B12 deficiency is more common in metformin use or gastric bypass. * **Vitamin A:** Phenytoin does not interfere with the absorption or metabolism of fat-soluble Vitamin A. **High-Yield Clinical Pearls for NEET-PG:** * **Fetal Hydantoin Syndrome:** Characterized by craniofacial anomalies (cleft lip/palate), microcephaly, and hypoplastic phalanges/nails. * **Vitamin K Deficiency:** Phenytoin can also cause a deficiency of Vitamin K in the newborn, leading to coagulation defects. Prophylactic Vitamin K is often given to the mother in the last month of pregnancy. * **Management:** Pregnant women on phenytoin should receive high-dose folic acid (5 mg/day) to mitigate the risk of NTDs.

Q: Which of the following medications is absolutely contraindicated for a mother who is breastfeeding her newborn baby?

Amphetamines. **Explanation:** The safety of medications during breastfeeding depends on the drug's concentration in breast milk, its oral bioavailability in the infant, and its potential for toxicity. **1. Why Amphetamines are the Correct Answer:** Amphetamines (Option A) are **absolutely contraindicated** during breastfeeding. They are highly lipophilic and concentrate in breast milk at levels much higher than maternal plasma. In newborns, they can cause significant CNS stimulation, leading to irritability, agitation, poor sleeping patterns, tachycardia, and potential long-term neurodevelopmental issues. Furthermore, amphetamines can suppress maternal prolactin levels, potentially interfering with milk production. **2. Analysis of Incorrect Options:** * **Carbamazepine (Option B):** Considered "compatible" with breastfeeding by the AAP. While it does enter breast milk, the amounts are usually sub-clinical. Monitoring for infant jaundice or sedation is advised, but it is not a contraindication. * **Labetalol (Option C):** This is a preferred beta-blocker in lactation because it is highly protein-bound, resulting in very low concentrations in breast milk. * **Ibuprofen (Option D):** The NSAID of choice for breastfeeding mothers. It has extremely low excretion into milk and a short half-life, making it safe for the infant. **3. NEET-PG High-Yield Pearls:** * **Absolute Contraindications to Breastfeeding (Maternal Drugs):** Anticancer drugs (antimetabolites), Radioactive isotopes (e.g., Iodine-131), Lithium, Ergotamine, Retinoids, and Drugs of abuse (Cocaine, Amphetamines). * **Safe Alternatives:** If a mother needs an antibiotic, **Penicillins/Cephalosporins** are preferred over Tetracyclines. For analgesia, **Paracetamol/Ibuprofen** are preferred over Aspirin (due to Reye’s syndrome risk). * **Rule of Thumb:** Drugs with high molecular weight, high protein binding, and low lipid solubility are less likely to cross into breast milk.

Q: Which parameter is most important for determining drug dosage in a child?

Weight. **Explanation:** **1. Why Weight is the Correct Answer:** In pediatric pharmacology, **Body Weight (kg)** is the most widely used and practical parameter for calculating drug dosages. This is because children undergo rapid physiological changes, and weight serves as a reliable proxy for the volume of distribution ($V_d$) and metabolic capacity. Most pediatric drug references (like the IPV or Nelson’s) provide dosages in **mg/kg/day**. While Body Surface Area (BSA) is technically the most accurate method for drugs with a narrow therapeutic index (like chemotherapy), weight remains the standard bedside parameter for general prescribing. **2. Why Other Options are Incorrect:** * **Age (B):** Age-based formulas (e.g., Young’s or Dilling’s rule) are largely obsolete. Age does not account for the significant variation in growth; two 5-year-olds can have vastly different weights, leading to potential under-dosing or toxicity. * **Height (C):** Height alone does not correlate well with the metabolic rate or the volume of distribution of most drugs. It is primarily used to calculate BSA or to assess growth milestones. * **Investigation Results (D):** While renal (creatinine) or hepatic function tests are crucial for *adjusting* doses in sick children, they are not the primary parameter for *determining* the initial baseline dose. **3. High-Yield Clinical Pearls for NEET-PG:** * **BSA Calculation:** The most accurate method for pediatric dosing is **Body Surface Area (BSA)**, calculated using the Mosteller formula: $\sqrt{\frac{Height(cm) \times Weight(kg)}{3600}}$. * **Clark’s Rule:** A classic (though less used) formula based on weight: $\text{Child Dose} = \frac{\text{Weight in lbs}}{150} \times \text{Adult Dose}$. * **Neonatal Caution:** In neonates, weight-based dosing must be adjusted for their higher total body water percentage and immature glucuronidation (e.g., risk of Gray Baby Syndrome with Chloramphenicol).

Q: The most common adverse effect particularly seen in young children because of the use of sodium valproate is:

Hepatitis. **Explanation:** **Sodium Valproate** is a broad-spectrum antiepileptic drug, but its use in the pediatric population requires extreme caution due to the risk of **idiosyncratic hepatotoxicity** [1], [2]. 1. **Why Hepatitis is Correct:** The most serious and potentially fatal adverse effect of valproate is **fulminant hepatitis (Hepatotoxicity)**. This risk is significantly higher in children **under the age of 2 years**, especially those on polytherapy or those with underlying metabolic/mitochondrial disorders (e.g., POLG mutations). The mechanism involves the formation of toxic metabolites like 4-pentenoic acid, which interfere with mitochondrial fatty acid oxidation. 2. **Analysis of Incorrect Options:** * **Loss of hair (Alopecia):** This is a common side effect of valproate (often resulting in curly hair regrowth), but it is not life-threatening and is seen across all age groups, not specifically "particularly" concerning in young children compared to hepatitis. * **Anorexia:** While gastrointestinal upset is common, valproate more frequently causes **increased appetite and weight gain** rather than anorexia. * **Tremor:** This is a dose-related side effect typically seen in older children and adults on long-term therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Valproate is highly teratogenic, causing **Neural Tube Defects** (Spina Bifida) by interfering with folate metabolism. * **Pancreatitis:** It is a known cause of acute hemorrhagic pancreatitis. * **Monitoring:** LFTs (Liver Function Tests) should be performed before and during the first 6 months of therapy. * **Other Side Effects (Mnemonic: VALPROATE):** **V**omiting, **A**lopecia, **L**iver toxicity, **P**ancreatitis/Platelets low, **R**etention of fat (Weight gain), **O**edema, **A**norexia (rarely), **T**remor/Teratogenicity, **E**ncephalopathy (Hyperammonemia).

Q: Gray baby syndrome is caused by which of the following drugs?

Chloramphenicol. **Explanation:** **Gray Baby Syndrome** is a serious and potentially fatal adverse reaction associated with the administration of **Chloramphenicol** in neonates (especially premature infants). **Why Chloramphenicol is the correct answer:** The syndrome occurs due to the physiological immaturity of the neonatal liver and kidneys. There are two primary mechanisms: 1. **Deficiency of Glucuronyl Transferase:** Neonates lack sufficient levels of this enzyme, which is required to conjugate chloramphenicol into its inactive form. 2. **Reduced Renal Excretion:** Immature kidneys cannot effectively excrete the unconjugated drug. This leads to toxic accumulation of the drug, causing mitochondrial injury. Clinical features include abdominal distension, vomiting, progressive cyanosis (giving the skin a characteristic **ash-gray color**), hypothermia, and cardiovascular collapse. **Why other options are incorrect:** * **Chlorpromazine:** An antipsychotic that can cause extrapyramidal symptoms or neonatal withdrawal if used during pregnancy, but not Gray Baby Syndrome. * **Phenytoin:** An antiepileptic known for **Fetal Hydantoin Syndrome** (cleft lip/palate, microcephaly) if taken during pregnancy, and gingival hyperplasia in children. * **Gentamycin:** An aminoglycoside primarily associated with **ototoxicity and nephrotoxicity** in all age groups. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** Immediate discontinuation of the drug; exchange transfusion or charcoal hemoperfusion may be required. * **Other Chloramphenicol Side Effects:** Dose-dependent bone marrow suppression and idiosyncratic **Aplastic Anemia** (most serious). * **Drug of Choice:** Chloramphenicol remains a backup for Typhoid fever and H. influenzae meningitis in specific settings, but its use is strictly limited in neonates.

Q: Which drug can cause hypertrophic pyloric stenosis?

Erythromycin. **Explanation:** **Erythromycin** is the correct answer. The association between macrolide antibiotics and **Infantile Hypertrophic Pyloric Stenosis (IHPS)** is a well-documented clinical phenomenon. **Mechanism:** Erythromycin acts as a **motilin receptor agonist**. Motilin is a hormone that stimulates gastrointestinal motility. In neonates, particularly those under 2 weeks of age, exposure to erythromycin (either directly or through breast milk) triggers intense, non-coordinated contractions of the pyloric antrum. This repetitive mechanical stress leads to muscular hypertrophy of the pylorus, resulting in gastric outlet obstruction. **Analysis of Options:** * **B. Erythromycin:** This is the most strongly associated drug. The risk is highest when administered in the first two weeks of life for conditions like pertussis prophylaxis or ophthalmia neonatorum. * **C. Azithromycin:** While some studies suggest a potential risk with azithromycin, the association is significantly weaker and less clinically established than with erythromycin. * **A. Rifampicin & D. Ampicillin:** These drugs are not associated with pyloric hypertrophy. Rifampicin is known for causing orange-colored secretions, and Ampicillin is a common cause of antibiotic-associated diarrhea or rashes. **NEET-PG High-Yield Pearls:** * **Clinical Presentation:** IHPS typically presents at 3–6 weeks of age with **non-bilious, projectile vomiting** and a palpable "olive-shaped" mass in the epigastrium. * **Metabolic Profile:** It causes **Hypochloremic, Hypokalemic Metabolic Alkalosis** (due to loss of HCl from the stomach). * **Drug of Choice for Pertussis:** Despite the risk of IHPS, macrolides remain the treatment of choice for Pertussis, but infants must be monitored closely for symptoms of vomiting.

Question 1

What is the effect of indomethacin on the ductus arteriosus?

Accepted Answer

Closure of the ductus in premature neonates

Answer

Patent ductus arteriosus

Answer

Closure of the ductus in term and premature neonates

Answer

Closure of the ductus in older children

Question 2

Dosage of a drug in a child is typically calculated based on which of the following parameters?

Accepted Answer

Weight

Answer

Race

Answer

Sex

Answer

Height

Question 3

What agent is used for pupil dilatation in children?

Accepted Answer

Atropine

Answer

Homatropine

Answer

Tropicamide

Answer

Phenylephrine

Question 4

Which vitamin deficiency is most commonly seen in a pregnant mother receiving phenytoin therapy for epilepsy?

Accepted Answer

Folic acid

Answer

Vitamin B6

Answer

Vitamin B12

Answer

Vitamin A

Question 5

Which of the following drugs are known to cause fetal renal anomalies?

Accepted Answer

Enalapril

Answer

Frusemide

Answer

Angiotensin receptor blocker

Answer

Amlodipine

Question 6

Which of the following medications is absolutely contraindicated for a mother who is breastfeeding her newborn baby?

Accepted Answer

Amphetamines

Answer

Carbamazepine

Answer

Labetalol

Answer

Ibuprofen

Question 7

Which parameter is most important for determining drug dosage in a child?

Accepted Answer

Weight

Answer

Age

Answer

Height

Answer

Investigation results

Question 8

The most common adverse effect particularly seen in young children because of the use of sodium valproate is:

Accepted Answer

Hepatitis

Answer

Loss of hair

Answer

Anorexia

Answer

Tremor

Question 9

Gray baby syndrome is caused by which of the following drugs?

Accepted Answer

Chloramphenicol

Answer

Chlorpromazine

Answer

Phenytoin

Answer

Gentamycin

Question 10

Which drug can cause hypertrophic pyloric stenosis?

Accepted Answer

Erythromycin

Answer

Rifampicin

Answer

Azithromycin

Answer

Ampicillin

Pediatric and Geriatric Pharmacology — MCQs

Pediatric and Geriatric Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?